We are live on
!
Find out more
VBIV
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
VBIV
Delisted
VBIV was delisted on the 7th of August, 2024.
41 hedge funds and large institutions have $1.79M invested in VBI Vaccines, Inc. New Common Stock (Canada) in 2024 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 5 increasing their positions, 11 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
167% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 3
14% more funds holding
Funds holding: 36 → 41 (+5)
11% more capital invested
Capital invested by funds: $1.61M → $1.79M (+$176K)
55% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 11
Holders
41
Holders Change
+5
Holders Change %
+13.89%
% of All Funds
0.59%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
5
Reduced
11
Closed
3
Calls
$543K
Puts
–
Net Calls
+$543K
Net Calls Change
+$59K
Top Buyers
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$21.9K |
| 2 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$17.5K |
| 3 |
AGC
Aspen Grove Capital
Avon,
Colorado
|
+$12.4K |
| 4 |
Simplex Trading
Chicago,
Illinois
|
+$12K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$10.4K |
Top Sellers
| 1 |
Goldman Sachs
New York
|
-$18.8K |
| 2 |
Renaissance Technologies
New York
|
-$17.8K |
| 3 |
AGM
Alpine Global Management
New York
|
-$15.1K |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$11.1K |
| 5 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
-$10.6K |
